SCHEMBL3956502

SCHEMBL3956502

Nc1ncc(Br)nc1NCCCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
TLR8 Q9NR97 4/20 0.45
TLR7 Q9NYK1 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
TMIGD3 P0DMS9 2/20 0.45
ADORA2A P29274 2/20 0.45
ADORA2B P29275 2/20 0.45
ADORA1 P30542 2/20 0.45
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ADK P55263 1/20 0.43
GBA1 P04062 1/20 0.43
APP P05067 1/20 0.43
PIK3CD O00329 1/20 0.42
PIK3R1 P27986 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557824 0.91 APP (0.51) TMIGD3ADORA2AADORA2BADORA1LMNA
SCHEMBL3952920 0.89 HPGD (0.49) HPGDTLR8TLR7CYP1A2CYP2D6
SCHEMBL18627615 0.82 LDHA (0.54) LMNAAPP
SCHEMBL557825 0.79 APP (0.51) TMIGD3ADORA2AADORA2BADORA1LMNA
SCHEMBL23461169 0.75 APP (0.47) TMIGD3ADORA2AADORA2BADORA1LMNA
SCHEMBL29904352 0.75 APP (0.47) TMIGD3ADORA2AADORA2BADORA1LMNA
SCHEMBL6212947 0.73 APP (0.48) HPGDCYP1A2CYP2D6CYP2C19TMIGD3
SCHEMBL3955508 0.73 ATR (0.49) HPGDCYP1A2CYP2D6CYP2C19LMNA
SCHEMBL12146478 0.71 ATR (0.35)
SCHEMBL15435182 0.71 HPGD (0.70) HPGDTMIGD3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed